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Background: Poisoning exposures continue to be a significant cause of morbidity and mortality worldwide. The
lack of facilities, treatment resources, and antidotes in hospitals may affect the treatments provided and outcomes.
This study aimed to determine the availability of gastrointestinal (GI) decontamination, stabilisation, elimination
enhancement resources, and antidotes for the management of acute toxic exposures and poisonings in emergency
departments (EDs) among various types of governmental and private hospitals in Palestine.
Methods: A cross-sectional study using semi-structured questionnaire was performed. Data were collected based
on hospital resources; GI decontamination, stabilisation, elimination enhancement resources and antidotes from
Palestinian hospitals.
Results: Eighteen hospitals (94.7%) have responded. Among them, paracetamol poisoning was the most frequently
reported cases by EDs (mean frequency score = 7.6 ± 2.1), followed by bee stings (mean = 6.9 ± 2.7) and
organophosphate poisoning (mean = 6.7 ± 2.7). The availabilities of most resources related to GI decontamination
items varied substantially with hospital type, but these differences were not statistical significant. The availability
of stabilisation resources was not significantly different between hospitals types. For the availability of techniques
used to enhance the elimination of toxic substances, there were variations between the hospitals types. However,
these differences were not statistical significant, except for haemodialysis (p = 0.003) which was more available in
governmental hospitals. For the availability of antidotes, none of the hospitals had sufficient stock of all antidotes
listed. In relation to hospital type, there was variability in the availability of antidotes, but this did not reach statistical
significance, except for deferoxamine (p < 0.001), which was available in all governmental hospitals but none of
the private hospitals.
Conclusions: The availability of treatment resources and antidotes in Palestinian hospitals was not adequate
except for stabilisation resources. The availability of such resources acts as a marker for the level of readiness of
hospital EDs in Palestine for the management of acute toxic exposure and poisoning. The implementation of a
minimum list of antidotes and treatment resources would be useful to increase the level of resources. Coordination
between Palestinian poison control and drug information centre and hospitals is also important.
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With the availability of a vast number of chemicals and
drugs, acute poisoning is a medical emergency [1,2] and
is considered one of the most common reasons for visit-
ing emergency departments (EDs). Poisoning exposures
continue to be a significant cause of morbidity and mor-
tality worldwide [3]. The National Vital Statistics Reports
showed that poisoning was the fifth leading cause of injury
and death in the United States of America in 2010 [4],
while the exact incidence of this problem in Palestine
remains uncertain and information available is limited
due to under-diagnosis and underreporting. The growing
incidence of poisoning has highlighted the importance for
countries to have special programs for poison control and,
in particular, the facilities for diagnosis, treatment, and
prevention of poisoning [5].
If a poisoning is recognised early and appropriate sup-
portive care is initiated rapidly, the majority of patient
outcomes will be good [6]. An example of this is the
treatment of patients diagnosed with paracetamol poi-
soning with N-acetylcysteine within 8 hours [7]. In
addition, the treatment of poisoning cases in the ED
begins with stabilising the patient and assessing the vital
signs, starting with ABC (airway, breathing and circula-
tion), which is sometimes followed by gastrointestinal
(GI) decontamination or the immediate use of an antidote
[6,8]. Supportive measures include the use of commonly
stocked medicines such as adrenaline and sodium
bicarbonate [9].
Furthermore, since the timely use of antidotes pre-
vents death and shortens the length of hospitalisation, as
well as reducing the patient’s pain and suffering, main-
taining a sufficient stock of antidotes is the responsibility
of any hospital that provides emergency health care [10].
If a poisoned patient needs a certain antidote that is not
available in a particular hospital, then the treatment op-
tions include supportive measures, borrowing antidotes
from another hospital or transferring the patient to the
other hospital [9].
To the best of our knowledge, there is a worldwide
lack of studies evaluating the preparedness and the avail-
ability of the necessary resources to treat poisoning
cases. Published research in this area has concentrated
mainly on the investigation of antidote availability and
preparedness for disaster management. Over the past
years, several studies have shown that the unavailability
of antidotes is common in health care facilities and suffi-
cient stocking of antidotes remains a problem worldwide
[9,11-19]. Also, there are no studies to date that have
addressed the level of preparedness of hospital EDs in
Palestine for the management of acute toxic exposure
and poisonings. Furthermore, only one attempt has been
made to identify the availability of antidotes in one dis-
trict in Palestine [20]. Since poisoning remains a seriousproblem in Palestine [3,21], and since various facilities
are frequently not available, we initiated a countrywide
survey to describe the availability of current facilities and
the anticipated requirements in Palestine. The purpose of
this study was to determine the availability of treatment
resources for the management of acute toxic exposures
and poisonings in EDs among various types of hospitals in
Palestine, and to compare the availability of such facilities
among various types of hospitals.
Methods
Study design
This was a cross-sectional survey study using semi-
structured questionnaire that involved descriptive and
comparative analysis.
Palestinian health system and services
Palestine, also known as the occupied Palestinian territor-
ies is located in the Middle East. The key player for the
health system and services in Palestine is the Palestinian
government through the Palestinian Ministry of Health
(PMOH). Other major providers of health care in
Palestine include the Palestinian Non-Governmental
Organizations (NGOs), the United Nations Relief and
Works Agency for Palestine Refugees in the Near East
(UNRWA), the Palestinian Military Medical Services
(PMMS) and private for profit organizations [22]. The
bulk of health services and health expenditure are pro-
vided by the PMOH through 458 primary health care
centers distributed all through the West Bank and Gaza.
The international refugee agency, UNRWA, operates 102
primary health care centers that provide free medical
services to Palestinians in refugee camps in the West
Bank and Gaza. The NGOs sector operates 206 primary
health care centers and general clinics while the PMMS
operates 23 primary health care centers and clinics dis-
tributed through different districts in West bank and
Gaza strip [23]. In the West bank, the PMOH listed 21
public hospitals with EDs, of which 12 were govern-
mental hospitals and 9 were private hospitals.
Study area and sample size
The data collection was conducted from July to October
2012, and the intention was to cover all hospitals (in-
cluding government and private hospitals).The primary
targets were the EDs from these hospitals that receive
poisoning cases, as well as the central pharmacy of each
hospital which was responsible for the availability of
treatment resources. A list of hospitals was extracted
from the Ministry of Health website (http://www.moh.
ps/attach/441.pdf, accessed 14 April 2012). A total of 21
hospitals were identified in the Palestinian West Bank,
and the addresses and contact information for each were
extracted and recorded; 12 were governmental hospitals
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to convenience sampling techniques for descriptive
studies, an 80% response rate is acceptable for inter-
view questionnaires.
Study tool: the questionnaire
A semi-structured questionnaire was developed for the
purpose of the present study (See Additional file 1). The
questionnaire was designed by the Poison Control and
Drug Information Centre (PCDIC) at An-Najah National
University in Palestine. It was prepared in English and
accompanied by an official document explaining the
purpose and importance of the survey. The question-
naire contained three sections. The first asked about the
epidemiological data pertaining to the types of poisoning
cases admitted. This section of the questionnaire was
designed to be self-administered by ED physicians. A list
of common toxic agents was compiled from the pub-
lished previous studies in Palestine [3,24,25]. The partici-
pants were asked to give an ascending ranking of the
exposures on this list according to their observed inci-
dence during the last year. The agent that was ranked
first (i.e. the most common exposure presenting to that
hospital) during the last year was given 10 points, while
the agent that was ranked last was given 1 point based
on ranking order method [26]. The resulting score is a
measure of the relative frequency with which a given
toxic agent was observed to cause exposure compared
to the other most common agents at a given ED in
Palestine and across the region, a higher score reflecting
an agent observed more frequently to cause exposure
leading to presentation at an ED. After summation of
the scores of all respondents, we obtained an aggregate
ranking of the ten most common toxic agent exposures
presenting to the hospitals in Palestine. The second
section was designed to indicate which resources were
available in their EDs, such as equipment for decon-
tamination, life support, and elimination enhancement
instruments. A list of commonly required resources used
for the treatment of acute poisoning was compiled from
the published recommendations [8,27,28].
The final section of the questionnaire consisted of
questions to indicate which antidotes they had available
in their hospital. A list of commonly required antidotes
and essential drugs used for treating poisoning complica-
tions was compiled from the World Health Organization
(WHO) and from published guidelines for antidote stock-
ing [11,29]. Furthermore, the availability of antidotes in
each hospital was compared to the 16 antidotes consid-
ered essential in the guidelines of Dart et al. for stocking
antidotes [11].
The director of each hospital was asked permission to
have the responsible participants complete the question-
naire. The heads of the ED departments were requestedto complete the first section, the director of the phar-
macy was requested to fill in the second section, and the
third section was completed by a specialist chosen by
the heads of the ED departments.
Ethical approval
This study received approval from the PMOH and
Institutional Review Board (IRB) at An-Najah National
University before the initiation of the study. Verbal
consent was obtained from the participants prior to
commencement of the study and the requirement for
written informed consent was waived. The IRB waived for
protocols that were clearly below minimal risk and the
research did not involve any therapeutic intervention.
Statistical analysis
Data extracted from the questionnaires were entered
into the Statistical Package for Social Sciences (SPSS
version 16) software. A descriptive comparative analysis
of statistical data is used. Continuous data are presented
as mean ± standard deviation (SD), and categorical data
are expressed as numbers with percentages. For com-
parative analysis, either the Chi square or the Fisher’s
exact test was used to test the statistical significance of
differences between categorical variables. A p value of
less than 0.05 was considered statistically significant.
Results
Eighteen hospitals returned the survey, resulting in a
response rate of 85.7% (Table 1). Table 2 shows the top
10 toxic agents most frequently reported by EDs to have
caused human exposure presenting at least once during
the last year at their hospital. By analysing the collected
data, paracetamol poisoning was ranked first (mean
frequency score = 7.6 ± 2.1 points), followed by bee
stings (mean = 6.9 ± 2.7 points) and organophosphates
(mean = 6.7 ± 2.7 points).
Availability of decontamination resources
The availability of decontamination resources varied
substantially according to hospital type. However, these
differences did not reach statistical significance. Con-
cerning the resources for performing decontamination
through gastric lavage (GL) in the poisoned patient,
nasogastric tubes were available in both types of hospi-
tals. The availability of orogastric tubes was less than
that of nasogastric tubes. According to activated char-
coal (AC) dosage form, AC syrup was found to be more
common than the tablet and powdered forms, and it was
available in the majority of EDs in the hospitals investi-
gated (83.3%). Furthermore, sorbitol, ipecac syrup, and
polyethylene glycol were almost never available, espe-
cially in governmental hospitals (Table 3).
Table 1 List of participating hospitals (18 hospitals)
Governmental hospitals (N = 10) Private hospitals (N = 8)
Khalil Souliman (Jenin District) Al Razi (Jenin District)
Thabet Thabet (Tulkarm District) Al Zakah (Tulkarm District)
Al Watani (Nablus District) Specialized Arab Hospital
(Nablus District)
Rafidia (Nablus District) Al Itihad (Nablus District)
Darwish Nazal (Qalqilya District) Al Makassad
(Jerusalem District)
Yaser Arafat (Salfit District) Al Ahli (Hebron District)
Jericho (Jericho District) Arab Society
(Bethlehem District)
Al-Hussein (Bethlehem District)
Princess Alia (Hebron District)
Palestine Medical Complex
(Ramallah District)
Table 3 Availability of decontamination resources
stratified by hospital type (n = 18)
Resources Total Private Government P-value
N = 18 (%) N = 8 (%) N = 10 (%)
Nasogastric tube 18 (100) 8 (100) 10 (100) >0.999
Orogastric tube 13 (72.2) 6 (75) 7 (70) >0.999
Charcoal tablet 4 (22.2) 3 (37.5) 1 (10) 0.275
Charcoal powder 5 (27.8) 2 (25) 3 (30) >0.999
Charcoal syrup 15 (83.3) 5 (62.5) 10 (100) 0.069
Magnesium sulphate 15 (83.3) 6 (75) 9 (90) 0.559
Sodium sulphate 11 (61.1) 6 (75) 5 (50) 0.367
Sorbitol 2 (11.1) 2 (25) 0 (0.0) 0.183
Ipecac syrup 3 (16.7) 3 (37.5) 0 (0.0) 0.069
Polyethylene glycol 1 (5.6) 1 (12.5) 0 (0.0) 0.444
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For stabilisation resources, 11 items which are useful in
monitoring or treating poisoned patients were consid-
ered. Differences in availability of such resources did not
reach significant difference by hospital type, as most
resources were found in both types of hospital.
Six items out of the 11 were available in all 18 hospi-
tals (100%). These items were blood pressure apparatus,
IV cannula, crystalloid, nasal catheter, oxygen mask, and
endotracheal tube. In addition, 3 items of the 11 were
available in more than 80% of all types of hospitals.
However, the availability of the remaining resources,
which include colloids, and, in particular, pacemakers,
was found to be less common (Table 4). However, the
availability of such resources was much better compared
to decontamination and elimination resources.Table 2 Top 10 toxic agents or classes most frequently
causing exposure reported by the emergency






Bee sting 6.9 2.7
Organophosphate 6.7 2.7
Scorpion bite 6.6 2.6
Kerosen 6.1 2.4
Snake bite 5.8 2.4
Non-steroidal anti-inflammatory drugs 5.4 2.6
Chlorine 5.1 2.3
Central Nervous System medications 5.1 2.3
Cardiovascular medications 2.5 1.6Availability of elimination enhancement resources
For the availability of techniques used to enhance the
elimination of toxic substances, there were variations be-
tween the hospitals types. However, these differences did
not reach statistical significance, except for haemodialysis
(p = 0.003), where the availability of this technique was far
better in governmental hospitals compared to private
hospitals (90% vs. 12.5%). Haemoperfusion, haemofiltration,
alkaline diuresis, acid diuresis, and peritoneal dialysis
were almost never available, especially in private hospi-
tals (Table 5).Availability of antidotes and essential drugs
The overall availability of each antidote in the first list
varied widely; it ranged from zero (for fomepizole, cyanide
kit and dimercaprol) to 100% (for atropine sulphate,Table 4 Availability of stabilisation resources stratified by
hospital type (n = 18)
Resources Total Private Government P-value
N = 18 (%) N = 8 (%) N = 10 (%)
Blood pressure
apparatus
18 (100) 8 (100) 10 (100) >0.999
IV cannula 18 (100) 8 (100) 10 (100) >0.999
Nasal catheter 18 (100) 8 (100) 10 (100) >0.999
Laryngeal mask airway 16 (88.9) 8 (100) 8 (80) 0.477
Oxygen mask 18 (100) 8 (100) 10 (100) >0.999
Endotracheal tube 18 (100) 8 (100) 10 (100) >0.999
Mechanical ventilator 16 (88.9) 7 (87.5) 9 (90) >0.999
Colloid 13 (72.2) 7 (87.5) 6 (60) 0.314
Crystalloid 18 (100) 8 (100) 10 (100) >0.999
Pacemaker 6 (33.3) 3 (37.5) 3 (30) >0.999
Electrical
defibrillation
17 (94.4) 7 (87.5) 10 (100) 0.444
Table 5 Availability of elimination enhancement
resources stratified by hospital type (n = 18)
Resources Total Private Government P-value
N = 18 (%) N = 8 (%) N = 10 (%)
Haemodialysis 10 (55.6) 1 (12.5) 9 (90) 0.003
Haemoperfusion 3 (16.7) 1 (12.5) 2 (20) >0.999
Haemofiltration 2 (11.1) 1 (12.5) 1 (10) >0.999
Alkaline diuresis 2 (11.1) 0 (0.0) 2 (20) 0.477
Acid diuresis 2 (11.1) 0 (0.0) 2 (20) 0.477
Peritoneal dialysis 1 (5.6) 0 (0.0) 1 (10) >0.999
Exchange transfusion 5 (27.8) 2 (25) 3 (30) >0.999
Table 7 Availability of other antidotes and essential
drugs in hospitals stratified by hospital type (n = 18)
Antidote list Total Private Government P-value
N = 18 (%) N = 8 (%) N = 10 (%)
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four antidotes were severely deficient in hospitals (avail-
able in less than 20% of all hospitals). Those included
digoxin immune Fab, polyvalent snake anti-venom, pra-
lidoxime, and pyridoxine. None of the responding hos-
pitals stocked all of the antidotes on the list.
In relation to hospital type, there is variability in the
availability of antidotes. However, these differences did
not reach statistical significance except for deferoxamine
(p < 0.001). Deferoxamine was available in all govern-
mental hospitals, but none of the private hospitals
stocked it. Atropine sulphate, calcium gluconate and so-
dium bicarbonate were available in all governmental and
private hospitals (Table 6).Table 6 Availability of recommended antidotes* stratified
by hospital type (n = 18)
Antidote list Total Private Government P-value
N = 18 (%) N = 8 (%) N = 10 (%)
Atropine sulphate 18 (100) 8 (100) 10 (100) >0.999
Calcium gluconate 18 (100) 8 (100) 10 (100) >0.999
Deferoxamine 10 (55.6) 0 (0.0) 10 (100) 0.000
Digoxin immune Fab 2 (11.1) 1 (12.5) 1 (10) >0.999
Dimercaprol 0 (0.0) 0 (0.0) 0 (0.0) >0.999
Ethanol (100%) 5 (27.8) 3 (37.5) 2 (20) 0.608
Fomepizole 0 (0.0) 0 (0.0) 0 (0.0) >0.999
Glucagon 8 (44.4) 6 (75) 2 (20) 0.054
Methylene blue 7 (38.9) 2 (25) 5 (50) 0.367
N-acetylcysteine 8 (44.4) 6 (75) 2 (20) 0.054
Naloxone 17 (94.4) 8 (100) 9 (90) >0.999
Polyvalent anti-venom 3 (16.7) 0 (0.0) 3 (30) 0.216
Pralidoxime 1 (5.6) 1 (12.5) 0 (0.0) 0.444
Pyridoxine 1 (5.6) 1 (12.5) 0 (0.0) 0.444
Sodium bicarbonate 18 (100) 8 (100) 10 (100) >0.999
Cyanide Kit 0 (0.0) 0 (0.0) 0 (0.0) >0.999
*According to guidelines from Dart et al. antidotes [11].The availability of other antidotes in the second list
varied widely from zero (for calcium disodium edetate)
to 100% (for flumazenil and vitamin k). All hospitals
stock flumazenil and vitamin k. In contrast, calcium dis-
odium edetate was the only antidote on the list that was
not available at any hospital.
By hospital type, the availability of essential drugs var-
ied substantially. However, these differences did not
reach statistical significance in all cases. Overall, the
availability of most items was excellent, ranging from
more than 70% to 100%, except for thiamine, iso-
proterenol, leucovorin, and physostigmine (Table 7).Discussion
The results of this study indicate that most Palestinian
hospitals have certain important immediate interventions
such as gastrointestinal decontamination techniques and
resources to enhance poison elimination. Currently, there
are no generally recognised specific criteria that define the
preparedness of an ED for the management of acute toxic
exposures and poisonings. A list of commonly required re-
sources and items which might be used for the treatmentAvailability of other antidotes
Calcium disodium
edetate
0 (0.0) 0 (0.0) 0 (0.0) >0.999
Epinephrine 14 (77.8) 6 (75) 8 (80) >0.999
Flumazenil 18 (100) 8 (100) 10 (100) >0.999
Isoproterenol 8 (44.4) 2 (25) 6 (60) 0.157
leucovorin 5 (27.8) 1 (12.5) 4 (40) 0.314
Protamine sulphate 17 (94.4) 7 (87.5) 10 (100) 0.444
Vitamin K 18 (100) 8 (100) 10 (100) >0.999
Physostigmine
salicylate
3 (16.7) 2 (25) 1 (10) 0.559
Availability of essential drugs
Dopamine 16 (88.9) 7 (87.5) 9 (90) >0.999
Bronchodilators 16 (88.9) 7 (87.5) 9 (90) >0.999
Corticosteroids 15 (83.3) 7 (87.5) 8 (80) >0.999
Antihistamines 18 (100) 8 (100) 10 (100) >0.999
Thiamine 1 (5.6) 1 (12.5) 0 (0.0) 0.444
Dextrose 16 (88.9) 8 (100) 8 (80) 0.477
Diazepam 17 (94.4) 8 (100) 9 (90) >0.999
Phenytoin 13 (72.2) 6 (75) 7 (70) >0.999
Morphine 17 (94.4) 8 (100) 9 (90) >0.999
NSAIDs 14 (77.8) 7 (87.5) 7 (70) 0.588
Abbreviation: NSAIDs Nonsteroidal anti-inflammatory drugs.
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ommendations [8,11,16,27-31].
Unfortunately, the data of the present study showed
that the resources required for performing GL, such as
nasogastric and orogastric tubes, were more common
than other preparations used to decrease the absorption
of toxic agents such as charcoal, laxatives, and WBI.
This finding is consistent with the result of a previous
study of poisoning in Palestine that showed among the
cases which had undergone a decontamination proced-
ure, GL was the most commonly used [3]. Use of other
decontamination resources, besides GL, which is as-
sumed to be still commonly practiced in the surveyed
hospitals of this study, was consistent with the common
practices recommended in the clinical literature [32-35],
which support the limited use of all types of GI decon-
tamination of acutely poisoned patients. Decontamination
of severely poisoned patients must only be undertaken
after careful consideration of the potential risks and bene-
fits of the decontamination practice [34-37].
The data of the present study also show that resources
for performing decontamination through GL, such as
nasogastric tubes, are available in all EDs of both hospital
types (100%). Based on American Academy of Clinical
Toxicology (AACT) and European Association of Poisons
Centres and Clinical Toxicologists (EAPCCT) recommen-
dations [38], there is no evidence showing that GL should
be used routinely in the management of poisonings. GL
should not be performed routinely, if at all, for the treat-
ment of poisoned patients. However, the results of this
study are not compatible the published recommendations,
which suggest that GL is still commonly practiced in the
surveyed hospitals. Serious risks of the procedure include
aspiration pneumonitis, dysrhythmias, fluid and electro-
lyte abnormalities, hypoxia, laryngospasm, and perforation
of the GI tract or pharynx [38,39].
The present study showed that ipecac syrup is not
available in more than 83.3% of EDs of both type of hos-
pitals. These findings are consistent with current recom-
mendations that indicate that ipecac syrup should not be
used routinely after poisoning exposures due to the lack
of evidence of improved outcomes and risks, including
reduced effectiveness of AC, delayed administration of
oral antidotes, aspiration pneumonitis, and other com-
plication of prolonged emesis [6]. Further, the study
showed that AC is not available in the majority of EDs.
However, charcoal syrup was available in 83.3% of the
surveyed hospitals. The administration of AC is consid-
ered a useful decontamination technique if a patient has
ingested a potentially toxic amount of a poison up to 1 hour
previously which is known to be adsorbed by charcoal [40].
Moreover, the data of this study indicate that the re-
sources for performing decontamination through whole
bowel irrigation (WBI), such as polyethylene glycol, arenot available in the majority of the EDs. Based on AACT
and EAPCCT recommendations, WBI should be consid-
ered only for potentially toxic ingestions of sustained-
release or enteric-coated drugs, and iron and lead toxicity,
particularly for patients presenting more than 2 hours
after drug ingestion and for acute drug poisoning. WBI
should be considered for poisoned patients who have
ingested large amounts of iron, as the levels of morbidity
in these patients are high and there is a lack of other alter-
native techniques for GI decontamination [34].
The administration of cathartics alone has no role in
the management of poisoning, and is not recommended
as a method of GI decontamination [37]. Despite this,
cathartics were available in the majority of EDs of the
hospitals surveyed in this study. Sorbitol was rarely
available, particularly in governmental hospitals. Contro-
versy remains over the use of cathartics to hasten elim-
ination of toxins from the gastrointestinal tract. Some
toxicologists still use cathartics routinely when giving AC
even though few data exist to support their efficacy [41].
The results of our study concerning the availability of
GI decontamination resources are consistent with the
Malaysian study performed by Awang et al. [8], except
for AC dosage form. The authors, through the survey
that they conducted, reported that the availability of
charcoal tablets was better than powdered form, and
that they were available in more than two-thirds of the
EDs. In addition, the authors did not evaluate the avail-
ability of charcoal syrup in their study, which was found
to be available in 83.3% of hospitals in our study.
Our present study showed that certain resources used
for the stabilisation of poisoned patients who presented
to EDs were commonly reported as available by Palestine
hospitals. A review of the published studies indicate that
supportive measures including maintenance of ABCs are
frequently necessary before confirmation of intoxication
[30,42,43]. Endotracheal intubation is not always neces-
sary, but if respiratory inadequacy is present, it is better to
secure the airway. Intubation is indicated in cases of acute
respiratory failure. Other specific indications include the
need for high levels of supplemental oxygen in carbon
monoxide poisoning cases, and the need to secure the
airway for gastric emptying [30]. Endotracheal intubation
reduces the risk of aspiration [44], this was consistent with
our findings, as the availability of endotracheal tubes was
100% in both types of hospitals. With regard to airway
support resources, all hospitals had IV cannulas, nasal
catheters, oxygen masks and endotracheal tubes.
Further, our findings regarding the availability of stabil-
isation resources were also compatible with the results of
Awang et al. [8], except for volume expanders (colloids), in
which their availability was much better and reached 100%.
In the present study, results showed that haemodialysis
was widely available in most hospitals, which might
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the elimination of specific toxic agents. Surprisingly,
among elimination enhancement resources, acid diuresis
was available in 11% of Palestinian hospitals. However,
acid diuresis is no longer recommended or used in poi-
soning treatment. It is a therapy which is associated with
significant risk and little benefit, and its use has been
abandoned [45]. In our study, it is unclear why the re-
spondents indicated that alkaline diuresis is nearly un-
available, however, the data indicated that intravenous
catheters, crystalloid and sodium bicarbonate were widely
available. This may be because the respondents are un-
familiar with the use of these agents in some poisoning
cases treatment, or the therapy is unavailable for some
reasons, e.g. inability to check blood gases due to unavail-
ability of arterial blood gas analyzer. It is clear that the
majority of governmental hospitals (e.g. haemodialysis re-
sources) perform some elimination enhancement tech-
niques as they have the proper facilities for that, whereas
most of the private hospitals do not perform them due
to the lack such of facilities. There were no apparent
differences in the availability of elimination enhancement
resources between Palestine and Malaysia, except for
peritoneal dialysis, which was available in 51.4% of the
Malaysian hospitals and was considered one of the most
common techniques used to enhance the elimination of
toxic substances [8].
Our results show that a large percentage of antidotes
are not available in the surveyed hospitals. Certain im-
portant antidotes, which are included in the essential
drugs list implemented by the PMOH, are not stocked
by a substantial number of hospitals, including govern-
mental hospitals. Examples of such antidotes include
pralidoxime for organophosphate poisoning and calcium
disodium edetate for heavy metal poisoning. The World
Health Organization (WHO) documented a serious short-
age in supplies of essential drugs and disposables reported
by the PMOH in Palestine. PMOH reported that 101
drugs (19% of 523 drugs on the essential drug list) and 61
medical disposables items (8% of 720 essential items) were
exhausted [46].
Among the hospitals, paracetamol toxic exposure was
the most frequently reported case by EDs, followed by
bee stings and organophosphate exposure. Surprisingly,
only two governmental hospitals had the antidote for
paracetamol poisoning (N-acetylcysteine) in stock. The
current study showed that few hospitals hold antidotes
for digoxin toxicity and isoniazid poisoning, which is in
keeping with findings reported from previous studies
that these antidotes are rarely requested [3,24]. In addition,
the availability of an antidote to treat individual patients
who have been poisoned with cyanide was inadequate, as
the 18 hospitals held no antidote. Furthermore, the avail-
ability of fomepizole, which is used as an antidote forethylene glycol and methanol toxicity, was the same
as that of the cyanide kit. As previously reported by
Al-Sohaim et al. [16] and Sawalha et al. [20], antidotes
used to treat conditions other than poisoning and toxic
drug exposure were more frequently stocked. Atropine
sulphate, calcium glyconate, dopamine, diazepam and
sodium bicarbonate were available in the majority of
hospitals of both types.
Allergic reaction to bee stings is like other allergic re-
actions. Mild reactions are treated with an antihistamine
such as diphenhydramine. If a more severe reaction de-
velops, epinephrine should be administered [47]. Epi-
nephrine was available in 77.8% of the surveyed hospitals.
This was also important, since anaphylaxis/allergic reac-
tion and serum sickness have been reported after the
administration of anti-venom for snake bites [10].
Our study is also the first in Palestine to assess the
antidotes stocked at a national level. Insufficient anti-
dote stocking is not a unique problem to Palestine. Our
findings are also consistent with studies from multiple
countries which report variable and inadequate antidote
stocking levels. A recent study carried out by Al-Sohaim
et al. [16] found that no hospital had sufficient stock of 16
antidotes. Wium and Hoffman [48] conducted a study in
South Africa. The results of the study revealed that
there was a problem with regard to the availability and
distribution of important antidotes, as none of the
responding hospitals stocked all of the antidotes on the
list. A similar study performed in north Palestine that
was carried out by Sawalha et al. [20] showed that the
number of antidotes stocked in all hospitals ranged from 5
to 12, but that no hospital stocked all 25 of the antidotes
listed. An Australian study carried out by Nissen et al. [15]
surveyed Queensland hospitals as to the level of stocks
held of 13 antidotes. This study reported that while most
hospitals stocked some important antidotes, no hospital
stocked all 13 and few hospitals had sufficient stocks to
treat an adult patient.
There has been no study exploring the reasons for in-
adequate antidote stocking in Palestine. Abbott et al. [9]
suggested some possible reasons for inadequate stocking
of antidote in their study in New Zealand. The extreme
rarity of needing the antidote due to the low frequencies
of poisonings was the most common reason for the low
availability of antidotes. High costs, short shelf-lives,
having agents that might have benefits in poisoning
management and a lack of clinical requests were other
contributory factors for inadequate stocking in the New
Zealand hospital pharmacies [9].
Strengths and limitations
The major strength of the current study is that it is the
first of its kind to assess the level of readiness of hospi-
tals for the management of acute toxic exposures and
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study to assess the antidotes stock level throughout
Palestine, except for Gaza, due to the lack of access and
mobility. There was a previous study carried out by
Sawalha et al. [20], where the authors conducted a sur-
vey that screened the stocking of specific antidotes at
hospitals in the north of Palestine only.
This study is subject to a number of limitations. The
objectives of the study were only to document the avail-
ability of immediate interventions (gastrointestinal de-
contamination techniques, patient stabilization resources
and methods to enhance elimination) and the availability
of antidotes and to evaluate the impact of hospital types
on the availability of these resources for the management
of acute toxic exposure and poisonings in Palestinian
hospitals. We did not study other factors that may deter-
mine the appropriateness of these resources and whether
those resources are specifically used for poisoning or for
other indications. Also, we have not performed a study
that clarifies the demographic, aetiological and clinical
characteristics of actual poisoning cases, as some poison-
ing cases that occur in the northern districts may differ
from those that occur in the southern districts; therefore,
we may find variety in the availability of antidotes between
districts. Furthermore, these study findings are based
entirely on a self-administered questionnaire survey. The
data collected depend upon the knowledge and respon-
siveness of the respondents, which carries inherent risks
of reporting error or bias. Thus, the results might not
reveal the current levels of readiness and antidote
stocks in Palestinian hospitals.
Conclusions and recommendations
This study looked at 18 hospitals. The availability of
treatment resources and antidotes in Palestinian hospi-
tals were not adequate, except for stabilisation resources.
According to hospital type, there was variability in the
availability of these resources, particularly in the avail-
ability of resources that enhance the elimination of poi-
son. Most Palestinian hospitals stocked some of the
surveyed antidotes. In relation to hospital type, there
was great variability in the availability of antidotes. The
availability of most antidotes was far better in govern-
ment hospitals compared to private hospitals. There are
no guidelines in place as to which antidotes should be
considered essential for use in Palestine, so specific anti-
dote stocking guidelines might be required and useful in
Palestinian hospitals. Coordination between PCDIC and
hospitals should be established regarding emergency fa-
cilities for the effective management of poisoning cases,
as well as the type and quantity of antidotes in each hos-
pital in order to direct the poisoned patients to the hospital
where the appropriate management resources and suitable
antidote are available. Since this study is descriptive innature, it serves as baseline data for further studies related
to acute toxic exposure and poisoning. In addition, we
need additional studies evaluating quantities of antidotes,
the clinical use of antidotes, the factors that affect the
availability of antidotes, the types of poisoning cases seen,
diagnostic equipment that would help treating the
undifferentiated poisoned patients, and the quality of
treatments provided to such cases at various hospitals
throughout Palestine.
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